Intergroup Contact Intervention for Nursing Undergraduates to Improve Aging Stereotype
Launched by HUZHOU UNIVERSITY · Sep 23, 2024
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
This research was designed as a pre-test-post-test randomized controlled experimental study. Nursing students from a university in Hangzhou, China served as the research subjects, who were randomly assigned to the experimental or control group. The control group received training in the regular course and was given compensatory intervention after the experiment, while the experimental group received intergroup contact training (the regular course combined with intergroup contact content). Such training was carried out in the forms of both individual and group interventions for a duration of...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • full-time undergraduate students enrolled in the nursing program
- • not yet enrolled in a geriatric nursing course
- • agreed to participate in this study and signed an informed consent form
- Exclusion Criteria:
- • students in the nursing program pursuing a bachelor degree through a vocational-to-degree pathway
- • Students who have taken a break from their studies
About Huzhou University
Huzhou University is a prominent educational and research institution located in Huzhou, China, dedicated to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, Huzhou University leverages its robust academic framework and interdisciplinary expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the global medical community. The university is committed to upholding the highest ethical standards in research, fostering collaborations with healthcare professionals, and translating scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Trial Officials
Meijuan Cao
Study Chair
Huzhou University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported